Effect of sodium glucose cotransporter 2 inhibitors on atrial tachy-arrhythmia burden in patients with cardiac implantable electronic devices.
Arwa YounisTania ArousRobert KlempfnerAdnan KharsaScott McNittSusan SchleedeBronislava PolonskiZeinab AbdallahRuppinder ButtarChristopher BodurianChadi TabajaHagai D YavinFarooq ShamrozOussama M WazniSteven D WittlinMehmet K AktasLlan GoldenbergPublished in: Journal of cardiovascular electrophysiology (2023)
Our real world findings suggest that in CIED HF patients, those with SGLT2i had a pronounced reduction in ATA burden and all-cause mortality when compared with those not on SGLT2i.